![Michael Handley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Handley
Directeur Général chez
VALION BIO, INC.
Fortune : 3 419 $ au 31/07/2026
Profil
Michael Kevin Handley was the founder of Vessix Vascular, Inc., founded in 2011, where the title held was Vice President-Regulatory, Clinical & Quality from 2011 to 2012.
Current jobs include Chief Executive Officer at Aletheia Therapeutics, Inc.; Chairman, President & Chief Executive Officer at Sparta Healthcare Acquisition Corp.
since 2021; Chief Executive Officer & Director at Valion Bio, Inc. starting 2026; and Director at Makamer Holdings, Inc., Reven Holdings, Inc., Aletheia Therapeutics Corp., and Makamer, Inc. Former jobs include President, Chief Executive Officer & Director at Cleveland BioLabs, Inc.; CEO, VP-Regulatory, Business Development & Quality at AccelaPure Corp.
from 2005 to 2007; Chief Executive Officer & Director at Marizyme, Inc. from 2018 to 2019; President, Chief Executive Officer & Director at Biostax Corp.
in 2020; President, Chief Executive Officer & Director at Cytocom, Inc.; Chief Executive Officer & Director at Armis Biopharma, Inc. from 2012 to 2018; President, Chief Executive Officer & Director at Statera Biopharma, Inc. from 2021 to 2025; Chairman at Medavate Corp.; Director at Coeptis Therapeutics, Inc. from 2021 to 2022; Chief Compliance Officer & VP-Regulatory at Spectranetics LLC from 2007 to 2010; Global Head-Regulatory at Acclarent, Inc. from 2010 to 2011; and Senior Principal at PRTM Management Consultants LLC.
Education includes an undergraduate degree from Colorado State University in 1995 and an MBA from Pepperdine Graziadio Business School in 2001.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VALION BIO, INC. 0,27 % | 30/06/2026 | 11 030 ( 0,27 % ) | 3 419 $ | 31/07/2026 |
Postes actifs de Michael Handley
| Sociétés | Poste | Début |
|---|---|---|
| HOMETOWN INTERNATIONAL, INC. | Directeur/Membre du Conseil | - |
| VALION BIO, INC. | Directeur Général | 03/03/2026 |
Makamer, Inc.
 Makamer, Inc. Chemicals: SpecialtyProcess Industries Manufactures and markets biodegradable compounds | Directeur/Membre du Conseil | - |
Sparta Healthcare Acquisition Corp.
 Sparta Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Directeur Général | 01/01/2021 |
Aletheia Therapeutics, Inc.
 Aletheia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | - |
Reven Holdings, Inc.
 Reven Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Directeur/Membre du Conseil | - |
Aletheia Therapeutics Corp.
 Aletheia Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Manufactures oncology products | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Handley
| Sociétés | Poste | Fin |
|---|---|---|
| STATERA BIOPHARMA, INC. | Directeur Général | 01/02/2025 |
| NAERODYNAMICS INC | Directeur/Membre du Conseil | 01/04/2022 |
| ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Michael Handley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Spectranetics LLC
 Spectranetics LLC Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices for cardiovascular surgeries | Health Technology |
Coeptis Therapeutics, Inc.
 Coeptis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies novel therapy products for cancer patients | Health Technology |
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to activate the immune system and address serious medical needs | Health Technology |
AccelaPure Corp.
 AccelaPure Corp. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical purification services | Health Technology |
Acclarent, Inc.
 Acclarent, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices | Health Technology |
PRTM Management Consultants LLC
 PRTM Management Consultants LLC Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Colorado State University
 Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vessix Vascular, Inc.
 Vessix Vascular, Inc. Pharmaceuticals: OtherHealth Technology Develops products to treat artery disease | Health Technology |
Marizyme, Inc.
 Marizyme, Inc. BiotechnologyHealth Technology Engages in development and commercialization of medical products and technologies | Health Technology |
Biostax Corp.
 Biostax Corp. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical & biotechnology products | Health Technology |
Makamer Holdings, Inc.
 Makamer Holdings, Inc. Food RetailRetail Trade Operates delicatessen stores | Retail Trade |
Cytocom, Inc. /Old/
 Cytocom, Inc. /Old/ BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies | Health Technology |
Reven Holdings, Inc.
Reven Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Tivic Health Systems, Inc.
 Tivic Health Systems, Inc. Medical SpecialtiesHealth Technology Manufactures bio-electrical sinus medical devices | Health Technology |
Aletheia Therapeutics, Inc.
Aletheia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Medavate Corp.
 Medavate Corp. BiotechnologyHealth Technology Develops and commercializes regenerative medicine | Health Technology |
Armis Biopharma, Inc.
 Armis Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharma products for the treatment and prevention of drug-resistant infections | Health Technology |
Pepperdine Graziadio Business School
 Pepperdine Graziadio Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aletheia Therapeutics Corp.
Aletheia Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Manufactures oncology products | Health Technology |
Sparta Healthcare Acquisition Corp.
Sparta Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Statera Biopharma, Inc.
 Statera Biopharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies | Health Technology |
Makamer, Inc.
Makamer, Inc. Chemicals: SpecialtyProcess Industries Manufactures and markets biodegradable compounds | Process Industries |
